Patent · US Active

Antibody molecule-drug conjugates and uses thereof

US11969476B2 · kind B2 · utility

0Cited by

11References

27Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

Karthik Viswanathan · Waltham, US
Kenneth Douglas Johnson · Marshfield, US
Obadiah J. Plante · Beverly, US
James C. Delaney · Cambridge, US
Tyree J. Koch · Seattle, US
Hamid Tissire · Abington, US
Andrew M. Wollacott · Boston, US
Boopathy Ramakrishnan · Braintree, US

Key dates

Filing date	Apr 2, 2021
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Apr 2, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.